Breaking News

Quincy Bioscience Receives NSF GMP Recertification

Manufacturing methods in accordance with FDA’s 21 CFR part 111

Quincy Bioscience has received recertification of its GMP facilities registered by NSF International for 2014. The GMP registration verifies that the company has the proper methods, equipment, facilities, and controls in place for producing dietary supplement products in accordance with the FDA’s 21 CFR part 111 regulations on manufacturing, packaging, and distribution.
 
“We’re proud to maintain this important recognition for all of our locations,” said Mark Underwood, president and co-founder of Quincy Bioscience. “We take good manufacturing practices very seriously in every department of our organization and we’re pleased that NSF continues to acknowledge our practice of excellence.”
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters